208 related articles for article (PubMed ID: 34429000)
1. Comprehensive population-based survey of migraine in Japan: results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) study.
Hirata K; Ueda K; Komori M; Zagar AJ; Selzler KJ; Nelson AM; Han Y; Jaffe DH; Matsumori Y; Takeshima T
Curr Med Res Opin; 2021 Nov; 37(11):1945-1955. PubMed ID: 34429000
[TBL] [Abstract][Full Text] [Related]
2. Burden of Migraine in Japan: Results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) Study.
Matsumori Y; Ueda K; Komori M; Zagar AJ; Kim Y; Jaffe DH; Takeshima T; Hirata K
Neurol Ther; 2022 Mar; 11(1):205-222. PubMed ID: 34862581
[TBL] [Abstract][Full Text] [Related]
3. Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
Lipton RB; Hutchinson S; Ailani J; Reed ML; Fanning KM; Manack Adams A; Buse DC
Headache; 2019 Nov; 59(10):1762-1772. PubMed ID: 31544244
[TBL] [Abstract][Full Text] [Related]
4. Potential Unmet Needs in Acute Treatment of Migraine in Japan: Results of the OVERCOME (Japan) Study.
Takeshima T; Ueda K; Komori M; Zagar AJ; Kim Y; Jaffe DH; Matsumori Y; Hirata K
Adv Ther; 2022 Nov; 39(11):5176-5190. PubMed ID: 36089637
[TBL] [Abstract][Full Text] [Related]
5. Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences.
Lipton RB; Munjal S; Alam A; Buse DC; Fanning KM; Reed ML; Schwedt TJ; Dodick DW
Headache; 2018 Oct; 58(9):1408-1426. PubMed ID: 30341895
[TBL] [Abstract][Full Text] [Related]
6. Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi-country results from the CaMEO-I study.
Buse DC; Sakai F; Matharu M; Reed ML; Fanning K; Dabruzzo B; Lipton RB
Headache; 2024 May; 64(5):469-481. PubMed ID: 38706199
[TBL] [Abstract][Full Text] [Related]
7. Burden and Unmet Needs in Migraine Patients: Results from the OVERCOME (Spain) Study.
Pascual J; Núñez M; Panni T; Díaz-Cerezo S; Novick D; Ciudad A
Pain Ther; 2023 Oct; 12(5):1209-1220. PubMed ID: 37458965
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study.
Schwedt TJ; Alam A; Reed ML; Fanning KM; Munjal S; Buse DC; Dodick DW; Lipton RB
J Headache Pain; 2018 May; 19(1):38. PubMed ID: 29797100
[TBL] [Abstract][Full Text] [Related]
9. Acute Treatment Patterns, Migraine Burden, and Healthcare Resource Use in People With Migraine: Results From the OVERCOME (EU) Observational Study.
Evers S; Dell'Agnello G; Novick D; Gonderten HS; Panni T; Pascual J
Pain Ther; 2024 Jun; 13(3):589-607. PubMed ID: 38625512
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis, consultation, treatment, and impact of migraine in the US: Results of the OVERCOME (US) study.
Lipton RB; Nicholson RA; Reed ML; Araujo AB; Jaffe DH; Faries DE; Buse DC; Shapiro RE; Ashina S; Cambron-Mellott MJ; Rowland JC; Pearlman EM
Headache; 2022 Feb; 62(2):122-140. PubMed ID: 35076091
[TBL] [Abstract][Full Text] [Related]
11. Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
Buse DC; Serrano D; Reed ML; Kori SH; Cunanan CM; Adams AM; Lipton RB
Headache; 2015 Jun; 55(6):825-39. PubMed ID: 25881857
[TBL] [Abstract][Full Text] [Related]
12. Preventive treatment patterns and treatment satisfaction in migraine: results of the OVERCOME (EU) study.
Pascual J; Panni T; Dell'Agnello G; Gonderten S; Novick D; Evers S
J Headache Pain; 2023 Jul; 24(1):88. PubMed ID: 37460942
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Acute Prescription Migraine Medication Use: Results From the CaMEO Study.
Hutchinson S; Lipton RB; Ailani J; Reed ML; Fanning KM; Adams AM; Buse DC
Mayo Clin Proc; 2020 Apr; 95(4):709-718. PubMed ID: 32247344
[TBL] [Abstract][Full Text] [Related]
14. Burden of Illness Among People with Migraine and ≥ 4 Monthly Headache Days While Using Acute and/or Preventive Prescription Medications for Migraine.
Buse DC; Yugrakh MS; Lee LK; Bell J; Cohen JM; Lipton RB
J Manag Care Spec Pharm; 2020 Oct; 26(10):1334-1343. PubMed ID: 32678721
[TBL] [Abstract][Full Text] [Related]
15. Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study.
Lipton RB; Munjal S; Buse DC; Alam A; Fanning KM; Reed ML; Schwedt TJ; Dodick DW
Headache; 2019 Sep; 59(8):1310-1323. PubMed ID: 31410844
[TBL] [Abstract][Full Text] [Related]
16. Pre- and post-headache phases of migraine: multi-country results from the CaMEO - International Study.
Lipton RB; Lanteri-Minet M; Leroux E; Manack Adams A; Contreras-De Lama J; Reed ML; Fanning KM; Buse DC
J Headache Pain; 2023 Nov; 24(1):151. PubMed ID: 37940856
[TBL] [Abstract][Full Text] [Related]
17. Predicting Inadequate Response to Acute Migraine Medication: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
Lipton RB; Munjal S; Buse DC; Fanning KM; Bennett A; Reed ML
Headache; 2016 Nov; 56(10):1635-1648. PubMed ID: 27731896
[TBL] [Abstract][Full Text] [Related]
18. Social burden of people with the migraine diagnosis in Japan: evidence from a population-based cross-sectional survey.
Igarashi H; Ueda K; Jung S; Cai Z; Chen Y; Nakamura T
BMJ Open; 2020 Nov; 10(11):e038987. PubMed ID: 33168555
[TBL] [Abstract][Full Text] [Related]
19. Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care.
Adams AM; Buse DC; Leroux E; Lanteri-Minet M; Sakai F; Matharu MS; Katsarava Z; Reed ML; Fanning K; Sommer K; Lipton RB
Cephalalgia; 2023 Jun; 43(6):3331024231180611. PubMed ID: 37314231
[TBL] [Abstract][Full Text] [Related]
20. A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related Disability.
Lipton RB; Manack Adams A; Buse DC; Fanning KM; Reed ML
Headache; 2016 Sep; 56(8):1280-9. PubMed ID: 27349336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
